Market Overview
ASX 200 Index
| Code | Company | Price | Change | % |
|---|
New super rules tax earnings for large balances, up to 40% on $10m+
Australian super rules tax earnings on large balances, up to 40% for $10m+, with unrealised gains removed; effective July 1, 2026; industry to consult in Jan.
Mortgage trap in later life: housing debt keeps Australians working longer
Australians risk retirement as property wealth masks crippling debt: half of 55–64 homeowners owe housing debt; average >$230k, pension gap widening.
Weekly wrap: A modest rise to end the week
The Australian share market enjoyed a modest rise to end the week on Friday after a Wall Street rally caused by optimism of more interest rate cuts in the future. The ASX 200 index closed up 0.5%, or 40 points, to close on 8628.2 points after eight of the 11 sectors rose.
Diverging Rates Pushing Up Aussie Dollar
At last the long-anticipated diverging interest rate outlook between Australia and the US is a reality and we can begin to see the effects it is already having.
AOK: California Moves & Surat Basin Push Ahead of 2026
Cobalt Blue: Kwinana Refinery Progress, Black Mass plan & 2026 Outlook
Axel Ree AXL: Rare Earths & Gallium in Brazil's Lithium Valley — Trial Mining Ahead
Mithril Silver & Gold (MTH.ASX): Copalquin District High-Grade Gold & Silver Upside
RooLife (RLG.ASX) Coffee Launch Sparks Growth with Data-Driven e-commerce
Boss Energy Targets New Well-Field Design to Optimise Honeymoon Operations after Strategic Review
A strategic review of Boss Energy’s (ASX: BOE) Honeymoon uranium project in South Australia has indicated an expected material deviation from the assumptions underpinning a 2021 enhanced feasibility study.
Why There Is a Ceasefire in the Bank Wars—For Now
The ceasefire between the banks in the war for deposits is still holding at this stage but it may not be long before we see it break out in earnest, after the revelation that Macquarie Bank now has more than $200 billion in retail and business deposits.
Calix Signs $35m Development Agreement with Rio Tinto for Zesty Green Iron Demonstration Plant
Calix (ASX: CXL) has made a significant breakthrough in its plans to develop a local green iron industry, with the signing of a $35 million joint development agreement with Rio Tinto (ASX: RIO).
The Lithium Turnaround: Pilbara, Liontown, IGO, MinRes, and Global Lithium Resources to Watch
Australia’s lithium industry is entering an exciting period. Global demand for lithium is rising sharply, electrification is accelerating, and Australia’s hard-rock lithium producers are perfectly positioned to benefit. From rising export earnings to operational leverage and selective growth opportunities, the fundamentals are compelling. We’ve captured the full story in a detailed report, including: Why lithium […]
Queensland backs Iltani to push Orient's potential in Herberton project
Iltani Resources secures an $8m QCMBTF investment to fast-track Herberton exploration, targeting Orient/Isabel zones, link-zone drill-out and VTEM targets.
Axel REE unveils significant Caladão REE and gallium increase
Axel REE jumps on Caladão Area B: maiden MRE lifts total REE to 572 Mt and gallium to 439 Mt; world-class, district-scale project eyeing 2026 trials.
Kingsrose Mining Hit with Penikat Permit Setback, Drilling Delayed
Small cap mining hopeful Kingsrose Mining (**KRM.ASX**) has announced a setback at its Penikat project in Finland. The news has put a temporary halt to the company's winter drilling program.
Atlantic Lithium Awaits Ewoyaa Mining Lease Ratification: What Investors Need to Know
Atlantic Lithium awaits Ghana Parliament ratification of the revised Ewoyaa Mining Lease, price-based royalty; approval uncertainty could hit project valuation.
Korean partner backs Invion’s INV043 ahead of Australia first-in-human trial
Invion (ASX: IVX) partners with Hanlim on a $2m non-clinical program to advance INV043 for oesophageal cancer toward first-in-human trials, backed by KDDF grant.
Neurizon Therapeutics Secures Over $44M in Funding to Advance HEALEY ALS Trial
Neurizon Therapeutics (ASX: NUZ) has successfully raised over **$44 million AUD** through a multi-pronged capital raise, securing funding to advance its lead drug candidate **NUZ-001** through the **H
TrivarX Reports Strong US Veteran Trial Results Supporting Objective Depression Screening
TrivarX (ASX: TRI) has delivered positive results from a US-based clinical trial that demonstrate clinically meaningful, objective detection of current major depressive episodes in veterans using the company’s single-lead electrocardiogram technology.
Island Pharmaceuticals and Texas Biomed to Conduct Non-Human Primate Studies Using Antiviral Drug Galidesivir
Island Pharmaceuticals (ASX: ILA) has secured a master service agreement with Texas Biomedical Research Institute to support the development of lead antiviral molecule galidesivir.
RocketBoots Secures $7M Placement to Fuel Global Expansion Post Major Contract Win
RocketBoots (ASX: ROC) has successfully raised A$7 million in a placement to sophisticated investors, a capital injection set to fuel its international expansion and capitalise on its recent transform
Adherium Surpasses CY2025 Shipment Milestones, Bolstering RPM Growth Strategy
Adherium (ADR.ASX) has announced it has surpassed its calendar year **2025** device shipment targets, delivering **4,666** devices against a goal of **4,000**, including **2,034** RPM devices against
DroneShield wins $6.2m Asia-Pacific military contract
DroneShield (ASX: DRO) has announced a new **A$6.2 million** contract for its counter-drone systems in the Asia-Pacific region, expected to be delivered and paid for in **2026**.
Archer’s Biochip: What Does Silicon Integration Mean?
For many investors, the word "silicon" calls to mind the computer revolution of the 80s and 90s, but for Archer Materials (ASX: AXE), it represents a potential lifeline for kidney disease patients and a pathway to scalable manufacturing for a medical device.
Vintage obtains Odin and Vali interest purchase extension
Vintage Energy extends deal to buy Metgasco/Bridgeport 25% in Odin and Vali gas fields; new targets Feb 28, 2026 and Mar 31, 2026 completion.
Invictus Energy set to ramp up Zimbabwe oil and gas hunt
Invictus Energy to fast-track Cabora Bassa in Zimbabwe after PPSA approval, eyeing Mukuyu's 20 Tcf gas and 845m barrels condensate, plus Musuma-1 upside.
Gold Hydrogen Further Confirms Potential of Ramsay Gas Development in SA
Gold Hydrogen (ASX: GHY) has taken a key step in realising the commercial potential of its Ramsay gas development in South Australia with drilling success at the Ramsay 4 well.
Mereenie Joint Venture Partners Sign Agreement with NT Government’s PWC for Long-Term Gas Supply
Horizon Oil (ASX: HZN) and partners Echelon Resources (ASX: ECH) and Central Petroleum (ASX: CTP) have signed an agreement with the Northern Territory to support an accelerated drilling program for four new wells at the Mereenie and Palm Valley fields.
FDA Greenlights Kava as Food, Boosting Calmer Co's US Expansion
The Calmer Co (ASX: CCO) has secured significant regulatory clarity from the US FDA, which confirmed traditionally prepared kava beverages as food products, de-risking its US expansion and dual-catego
The Calmer Co International Closes Second Tranche of $1.4 Million Convertible Note Raise
The Calmer Co International (ASX: CCO) has closed the second tranche of its previously announced secured convertible note raise, completing the planned $1.4 million funding round.
Southern Cross Electrical Engineering Awarded Data Centre and Rail Contracts Totalling $90 Million
Southern Cross Electrical Engineering (ASX: SXE) has secured awards totalling $90 million across the data centre and rail sectors through various group subsidiaries.
Hazer Group to Collaborate on Whyalla Clean Steel Bid with M Resources Partnership
Hazer Group (ASX: HZR) has entered a binding memorandum of understanding with M Resources to supply low-cost clean hydrogen and graphite technology for the proposed acquisition of the Whyalla steelworks in South Australia.
Never Miss a Market Move
Get the latest ASX small-cap news, exclusive CEO interviews, and market insights delivered to your inbox.
Free weekly newsletter. Unsubscribe anytime.
Ceretas secures $1m for breakthrough ultrasound therapy for dementia, eyes potential IPO
Australian MedTech company Ceretas has successfully secured $1 million in seed funding to advance its low-cost, portable and non-invasive ultrasound device aimed at treating dementia and other neurological conditions. This funding positions the company closer to a potential IPO as it progresses through clinical research and regulatory steps. Initial capital raise fuels development The recent […]
Stormeur IPO to expand non-surgical cosmetics empire
Non-surgical cosmetics group Stormeur has launched a $7 million capital raising to fund the opening of four new Cosmetique clinics along Australia’s east coast. The company announced an initial public offering (IPO) last month based on a growth strategy that includes two new clinics in Sydney and two in Melbourne, to be established within 24 […]
ASX anticipates surge of IPOs later in 2024
Australia’s pipeline of initial public offerings (IPOs) is expected to ramp up in the new year thanks to a cyclical market on the rebound. Anticipated listings for the second half of 2024 include companies in the industrials, mining and consumer discretionary sectors such as cars, household appliances, specialty items, luxury goods and leisure. According to […]
Guzman y Gomez sets sights on ASX listing with IPO to fund aggressive expansion
In a bold move set to shake up Australia’s fast food landscape, Mexican-inspired chain Guzman y Gomez (GYG) is preparing to make its debut on the Australian Securities Exchange (ASX). The company’s upcoming initial public offering (IPO) is not just another corporate event—it’s a statement of GYG’s ambition to redefine fast food in this country. […]